- Home
- BCLI vs OMEX Comparison
BCLI vs OMEX Comparison
Compare BCLI & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- OMEX
- Stock Information
- Founded
- BCLI 2000
- OMEX 1986
- Country
- BCLI United States
- OMEX United States
- Employees
- BCLI N/A
- OMEX N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- OMEX Marine Transportation
- Sector
- BCLI Health Care
- OMEX Consumer Discretionary
- Exchange
- BCLI Nasdaq
- OMEX Nasdaq
- Market Cap
- BCLI 9.8M
- OMEX 11.0M
- IPO Year
- BCLI N/A
- OMEX N/A
- Fundamental
- Price
- BCLI $1.16
- OMEX $1.21
- Analyst Decision
- BCLI Strong Buy
- OMEX
- Analyst Count
- BCLI 1
- OMEX 0
- Target Price
- BCLI $30.00
- OMEX N/A
- AVG Volume (30 Days)
- BCLI 412.8K
- OMEX 2.6M
- Earning Date
- BCLI 08-13-2025
- OMEX 08-08-2025
- Dividend Yield
- BCLI N/A
- OMEX N/A
- EPS Growth
- BCLI N/A
- OMEX N/A
- EPS
- BCLI N/A
- OMEX 0.23
- Revenue
- BCLI N/A
- OMEX $700,613.00
- Revenue This Year
- BCLI N/A
- OMEX N/A
- Revenue Next Year
- BCLI N/A
- OMEX N/A
- P/E Ratio
- BCLI N/A
- OMEX $5.27
- Revenue Growth
- BCLI N/A
- OMEX N/A
- 52 Week Low
- BCLI $0.72
- OMEX $0.27
- 52 Week High
- BCLI $6.45
- OMEX $5.46
- Technical
- Relative Strength Index (RSI)
- BCLI 49.98
- OMEX 54.37
- Support Level
- BCLI $1.02
- OMEX $1.08
- Resistance Level
- BCLI $1.32
- OMEX $1.43
- Average True Range (ATR)
- BCLI 0.09
- OMEX 0.15
- MACD
- BCLI -0.00
- OMEX -0.01
- Stochastic Oscillator
- BCLI 46.67
- OMEX 27.27
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.